Showing results (241-250 of 296) with videos related to
Sort By:
Pageof 30
Vox Sanguinis|June 14, 2020
Guidance for the procurement of COVID-19 convalescent plasma: differences between high- and low-middle-income countriesEvan M Bloch, Ruchika Goel, Silvano Wendel, et al.Expert Review of Anti-Infective Therapy|January 27, 2026
COVID-19 convalescent plasma safety and efficacy analysis for biologics license application approvalDavid J Sullivan, Rita Reik, Alicia Prichard, et al.Medrxiv : the Preprint Server for Health Sciences|October 21, 2021
Differentiation of SARS-CoV-2 naturally infected and vaccinated individuals in an inner-city emergency departmentEvan J Beck, Yu-Hsiang Hsieh, Reinaldo E Fernandez, et al.BMC Immunology|February 17, 2022
Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2Harini Natarajan, Shiwei Xu, Andrew R Crowley, et al.Medrxiv : the Preprint Server for Health Sciences|August 17, 2021
Antibody Attributes that Predict the Neutralization and Effector Function of Polyclonal Responses to SARS-CoV-2Harini Natarajan, Shiwei Xu, Andrew R Crowley, et al.Journal of Clinical Microbiology|January 19, 2022
Differentiation of Individuals Previously Infected with and Vaccinated for SARS-CoV-2 in an Inner-City Emergency DepartmentEvan J Beck, Yu-Hsiang Hsieh, Reinaldo E Fernandez, et al.Vox Sanguinis|September 14, 2022
Early and out-of-hospital use of COVID-19 convalescent plasma: An international assessment of utilization and feasibilityArwa Z Al-Riyami, Lise Estcourt, Naomi Rahimi-Levene, et al.Cell|August 19, 2022
Organizations in science and medicine must hold each other accountable for discriminatory practicesJulie K Silver, Garrett S Booth, Archana Chatterjee, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2023
Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019Evan M Bloch, Daniele Focosi, Shmuel Shoham, et al.Vox Sanguinis|February 12, 2021
ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 Working GroupRuchika Goel, Evan M Bloch, France Pirenne, et al.Pageof 30